4//SEC Filing
Ackermann Michael 4
Accession 0001209191-22-037924
CIK 0001819790other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:51 PM ET
Size
8.4 KB
Accession
0001209191-22-037924
Insider Transaction Report
Form 4
Ackermann Michael
Director10% Owner
Transactions
- Exercise/Conversion
Common Stock
2022-06-15+4,257→ 1,208,273 total - Exercise/Conversion
Restricted Stock Units
2022-06-15−4,257→ 0 total→ Common Stock (4,257 underlying)
Holdings
- 100,000(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.
- [F2]The Reporting Person is the trustee of the Ackermann & Elmen-Gruys Trust Dated June 24, 2014 and has voting and dispositive power with respect to these shares.
- [F3]Each RSU represents a contingent right to receive one share of the Company's common stock.
- [F4]RSUs granted on June 15, 2021 in connection with the Reporting Person's service as a non-employee director as of the Company's 2021 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001791249
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 4:51 PM ET
- Size
- 8.4 KB